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1) Department of Internal Medicine, Seoul National University College of Medicine, Seoul and 2) Department of Infectious Disease, Chonnam National University
Medical School, Gwang-ju, Republic of KoreaAbstractIdentiﬁcation of the causative microorganism is important in the management of pyogenic vertebral osteomyelitis (PVO). The aim of this study
was to investigate whether culture positive rates differ between needle biopsy sites in patients with PVO, and which tissues are best for
microbiological diagnosis. Between January 2005 and December 2013, we conducted a retrospective cohort study of PVO patients who
had soft-tissue abscesses (paraspinal or psoas abscesses) and who received needle biopsy for microbiological diagnosis. Needle biopsy
sites were classiﬁed into two anatomical categories: vertebral bodies, or soft tissues (intervertebral discs, paraspinal abscesses, or psoas
abscesses). A generalized estimating equation model was developed to identify factors associated with tissue-culture positivity. During the
study period a total of 136 tissues were obtained by needle biopsy from 128 PVO patients with soft-tissue abscesses. The culture
positive rates of vertebral bodies and soft tissues were 39.7% (29/73), and 63.5% (40/63), respectively (p < 0.05). In a multivariate
analysis, male gender (adjusted odds ratio (aOR) 2.24, 95% CI 1.00–5.02), higher C-reactive protein (aOR 1.07, 95% CI 1.01–1.15),
positive blood culture (aOR 2.57, 95% CI 1.01–6.59), and soft tissues as biopsy site compared with vertebral bodies (aOR 2.28, 95% CI
1.08–4.78) were independent factors associated with tissue culture positivity. Soft tissues were the best sites for microbiological
diagnosis in PVO patients undergoing needle biopsy.
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KoreaClinical Microbiology and Infection © 2015 European Society of CIntroductionPyogenic vertebral osteomyelitis (PVO) is an infectious disease of
the vertebrae or paravertebral structures caused by a variety of
bacteria. Because long-term antibiotic treatment is essential, and
antibiotic choice depends on susceptibility tests, it is important to
identify the causative microorganism. Blood cultures and/or tis-
sue cultures are recommended for this purpose. Several factors
inﬂuence culture positivity rates [1–5]. Paravertebral abscesses,
elevated C-reactive protein (CRP), and elevated erythrocyte
sedimentation ratewere associatedwith higher culture positivity,
whereas previous antibiotic exposure was associated with
negative results of culture in some studies [2,4–8].Clin Microbiol Infect 2015; 21: 931–935
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.cmi.2015.06.021
932 Clinical Microbiology and Infection, Volume 21 Number 10, October 2015 CMITissue culture specimens can be obtained by needle or
surgical biopsy. The microbiological yield of surgical biopsy is
higher than that of needle biopsy [3,9,10]. However surgical
biopsy requires anaesthesia and incision of the skin, and
percutaneous needle biopsy is known to be safe [11–13]. For
these reasons, needle biopsy is generally preferred to surgical
biopsy as the initial diagnostic approach.
Tissues for microbiological diagnosis can be obtained by
needle biopsy from vertebral bodies, intervertebral discs and
soft-tissue abscesses (paraspinal abscesses or psoas abscesses).
As tissue-culture positivity rates could differ between biopsy sites
it would be better to choose biopsy sites which have higher
culture positivity rates when performing needle biopsies in pa-
tients with PVO. Little is known about which tissues are the best
biopsy sites for microbiological diagnosis in PVO [4,14–16].
The primary objective of this study was to investigate factors
associated with culture positivity of tissues obtained by needle
biopsy in patients with PVO. We also compared the rates of
culture positivity of tissue specimens obtained from vertebral
bodies and soft tissues, as a secondary objective, to determine
which tissues are most suitable for microbiological diagnosis.MethodsWe conducted a retrospective cohort study at three university-
afﬁliated teaching hospitals from January 2005 through
December 2013. All of the study hospitals were tertiary
referral centres and had 900–1700 beds.
Patients with PVO who had soft-tissue abscesses (paraspinal
abscesses and/or psoas abscesses) and had undergone needle
biopsy for tissue culture were investigated. PVO was diagnosed
when the causative microorganism was isolated from spinal or
paraspinal tissues, or if there were compatible clinical signs or
symptoms and radiological evidence of vertebral infection.
Compatible signs or symptoms were deﬁned as pain, fever, or
neurological manifestations. Characteristic radiographic
changes included decreased signal intensity in the vertebral
body and disc and loss of end plate on T1-weighted images, and
increased signal intensity of the disc and vertebral body on T2-
weighted images on magnetic resonance imaging.
Needle biopsy sites were classiﬁed into two anatomical cate-
gories: vertebral bodies, or soft tissues (intervertebral discs,
paraspinal abscesses or psoas abscesses). Patients <18 years, or
who had undergone surgical biopsy for tissue culture were
excluded, aswere patientswith vertebral osteomyelitis caused by
Mycobacterium tuberculosis or fungi. Patients who had been
exposed to antibiotics in the 2 weeks before obtaining tissue by
needle biopsy were also excluded. When coagulase-negative
staphylococci grew in tissue culture they were considered theClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecttrue pathogen if one or both of the following criteria wasmet: the
same organism grew in blood culture, or the same organism grew
in two or more spinal tissue specimens.
We collected data about baseline characteristics (age,
gender), underlying diseases, spinal surgery and procedures
within the year before diagnosis of pyogenic spondylitis, clinical
characteristics (pain, fever, neurological deﬁcit), laboratory data
(white blood cell counts, CRP levels) and radiographic data
(vertebral region involved, presence and location of abscess).
Statistical analysis
The Mann–Whitney U test was used to compare continuous
variables, and the chi-squared test was used to compare cate-
gorical variables. If the expected number of instances of a given
outcome was <5, Fisher’s exact test was used. Multivariate
analysis was performed to investigate the factors inﬂuencing
tissue culture positivity in patients with PVO. Because needle
biopsies were performed at two anatomical sites in a propor-
tion of patients, a generalized estimating equation model was
used to take account of a possible clustering effect of multiple
specimens from the same patient. We entered all variables that
were statistically signiﬁcant in univariate analysis into the
generalized estimating equation model. All P values were two-
tailed, and P < 0.05 was considered statistically signiﬁcant.
Statistical analysis was performed using the SPSS program
(version 20.0, SPSS Inc., Chicago, IL, USA).ResultsDuring the study period 567 patients >18 years were diagnosed
as having pyogenic vertebral osteomyelitis. Of these, 439 were
excluded for the following reasons: antibiotic exposure before
obtaining a tissue specimen (n = 201), percutaneous needle
biopsy not performed (n = 179) and absence of abscess
(n = 59). Ultimately a total of 136 tissues from 128 PVO pa-
tients with soft-tissue abscesses were included in the analysis. In
120 of the patients, tissues were obtained from one anatomical
category, and in eight patients they were obtained from two
anatomical categories. Of the tissues used for culture, 53.7%
(73/136) and 46.3% (63/136) were obtained from vertebral
bodies and from soft tissues, respectively. Intervertebral discs,
paraspinal abscess and psoas abscess comprised 27.0%, 54.0%
and 19.0% of the 63 soft tissues, respectively.
The culture positive rates of vertebral bodies and soft tissues
were 39.7% (29/73) and 63.5% (40/63), respectively (p 0.006).
Among soft tissues, the culture positive rates of intervertebral
discs, paraspinal abscesses and psoas abscesses were 52.9% (9/
17), 70.6% (24/34) and 58.3% (7/12), respectively (for disc
versus abscess p 0.290). Of the tissues obtained from twoious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 931–935
TABLE 1. Demographic, clinical, laboratory and radiographic
characteristics of patients with pyogenic vertebral
osteomyelitis according to biopsy site
Variable
Biopsy site
Vertebral body
(n [ 73)
Soft tissue
(n [ 63) p
Age (years)a 68 (56–76) 65 (53–73) 0.195
Sex (male) 44 (60.3%) 41 (65.1%) 0.564
Underlying Disease
Diabetes mellitus 11 (15.1%) 20 (31.7%) 0.021
Liver cirrhosis 7 (9.6%) 4 (6.3%) 0.490
Chronic kidney disease 2 (2.7%) 8 (12.7%) 0.044b
Solid tumour 5 (6.8%) 6 (9.5%) 0.568
Haematological disease 2 (2.7%) 1 (1.6%) 1.000b
Predisposing condition
Epidural block 15 (20.5%) 10 (15.9%) 0.483
Spine surgery or vertebroplasty 14 (19.2%) 15 (23.8%) 0.511
Presentation
Fever 22 (30.1%) 28 (44.4%) 0.084
Duration of spine pain (days)a 23 (7-56) 15 (5-30) 0.156
Spine area pain 72 (98.6%) 62 (98.4%) 1.000b
Radiating pain 41 (56.2%) 35 (55.6%) 0.943
Tingling sensation 8 (11.0%) 8 (12.7%) 0.754
Motor dysfunction, sensory
deﬁcit, paralysis
7 (9.6%) 6 (9.5%) 0.990
Sepsis 18 (24.7%) 20 (31.7%) 0.358
White blood cells count
(× 103/μL)
9,000
(7,050–12,950)
10,300
(7,800–13,600)
0.235
C-reactive protein (mg/dL) 5.3 (2.3-10.9) 7.1 (3.7-17.5) 0.032
Involved spine
Cervical spine 1 (1.4%) 5 (7.9%)
Cervicothoracic spine 1 (1.4%) 0
Thoracic spine 12 (16.4%) 9 (14.3%)
Thoracolumbar spine 6 (8.2%) 3 (4.8%)
CMI Kim et al. Best tissues for culture in spondylitis 933anatomical categories in the eight patients, concordant results
were observed in seven patients and discordant ones in one. In
the patient whose culture results were discordant, a negative
result was obtained from a vertebral body and a positive result
was obtained from soft tissue. The most common causative
organism was Staphylococcus aureus (n = 34), of which 22 were
methicillin susceptible, followed by coagulase-negative staphy-
lococci (n = 12), streptococci (n = 8), Escherichia coli (n = 11)
and Klebsiella pneumoniae (n = 3), and some of the above were
cultured only from blood.
The demographic, clinical, laboratory and radiographic
characteristics of patients according to the sites of the tissues
obtained are summarized in Table 1. Diabetes mellitus and
chronic kidney disease were more common and CRP levels
were signiﬁcantly higher in those patients whose biopsies were
obtained from soft tissues. In a multivariate logistic regression
analysis to identify factors associated with tissue culture posi-
tivity, male gender (adjusted odds ratio (aOR) 2.24, 95% CI
1.00–5.02), higher CRP (aOR 1.07, 95% CI 1.01–1.15), positive
blood culture (aOR 2.57, 95% CI 1.01–6.59) and soft tissues as
biopsy site compared with vertebral body (aOR 2.28, 95% CI
1.08–4.78) were independent factors identiﬁed (Table 2).
Lumbar spine 48 (65.8%) 42 (66.7%)
Lumbosacral spine 5 (6.8%) 4 (6.3%)
No. of vertebrae involved
2 61 (83.6%) 45 (71.4%) 0.089
3 12 (16.4%) 18 (28.6%)DiscussionPresence of abscess
Epidural abscess 46 (63.0%) 47 (74.6%) 0.147
Paravertebral abscess 64 (87.7%) 51 (81.0%) 0.280
Psoas abscess 21 (28.8%) 23 (36.5%) 0.336
Blood culture positivityc 24 (42.9%) 28 (52.8%) 0.323
Tissue culture positive rate 29 (39.7%) 40 (63.5%) 0.006
Microorganism obtained by tissue culture
Methicillin susceptible
Staphylococcus aureus
9 (31.0%) 13 (32.5%)
Methicillin-resistant
Staphylococcus aureus
4 (13.8%) 4 (10.0%)
Coagulase-negative
Staphylococcus
2 (6.9%) 7 (17.5%)
Streptococcus 3 (10.3%) 3 (7.5%)
Escherichia coli 4 (13.8%) 4 (10.0%)
Others 7 (24.1%) 9 (22.5%)
aMedian (interquartile range).
bFischer’s exact test.
cBlood culture was performed in 56 patients in the vertebral body group, and 53
patients in the soft tissue group.The independent factors that we have found by multivariate
analysis to be associated with culture positivity of tissues ob-
tained by needle biopsy in patients with PVO were male gender,
higher CRP, positive blood culture and soft tissues as biopsy
site. Culture positive rates were signiﬁcantly higher when
specimens were obtained from soft tissues (intervertebral discs,
paravertebral abscesses or psoas abscesses) than when they
were obtained from vertebral bodies.
Several factors have been reported to inﬂuence culture
positivity of percutaneous needle biopsies in patients with PVO.
Culture positive rates were higher with surgical sampling, even
when minimally invasive techniques were used [17]. They were
also higher in patients with paravertebral abscesses, or higher
levels of inﬂammatory markers such as CRP and erythrocyte
sedimentation rate [2]. In contrast, biopsy yields were found to
be reduced by previous antibiotic exposure [2,4,5]. Three re-
ports investigating the culture positivity of biopsies at different
tissue sites found that rates were highest for paravertebral
abscesses. In one study, 29 tissue cultures were evaluated and
the culture positive rate from paravertebral abscesses was 43%;
this was higher than the 10% rate from other tissues, but the
difference was not statistically signiﬁcant [14]. In the second
study, the culture positive rate was 80% (8/10) in abscesses and
26.7% (8/30) in lumbar tissues [15]. In the third study, the rateClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologywas 61% (8/13) in spinal/epidural abscesses and 44% (12/27) in
vertebral bodies [16]. All three studies had the limitations that
less than 50 tissue cultures were investigated, that tissues were
obtained either by needle or surgical biopsy, and that no sta-
tistical analysis was performed to control for confounding
variables.
In the present study white blood cell counts and CRP levels
were signiﬁcantly higher in patients whose culture specimens
were obtained from soft tissues than in those from vertebral
bodies. We used multivariate analysis to control for other
factors inﬂuencing tissue culture positivity, and the multivariateand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 931–935
TABLE 2. Multivariate logistic regression analysis of factors associated with tissue culture positivity in patients with pyogenic
vertebral osteomyelitis
Culture negative Culture positive Odds ratio p Adjusted odds ratio p
Age (years), median (interquartile range) 67 (55–76) 65 (55–73) 0.99 (0.96–1.01) 0.314
Sex
Female 29 (47.5%) 19 (28.4%) 1.00 0.026 1.00 0.049
Male 32 (52.5%) 48 (71.6%) 2.29 (1.10–4.76) 2.24 (1.00–5.02)
Diabetes mellitus 11 (18.0%) 20 (29.9%) 1.93 (0.84–4.47) 0.119
Liver cirrhosis 6 (9.8%) 5 (7.5%) 0.74 (0.21–2.56) 0.632
Chronic kidney disease 6 (9.8%) 4 (6.0%) 0.58 (0.16–2.17) 0.517
Solid tumour 3 (4.9%) 8 (11.9%) 2.62 (0.66–10.37) 0.157
Haematological disease 1 (1.6%) 2 (3.0%) 1.85 (0.16–20.89) 1.000
Epidural block 15 (24.6%) 9 (13.4%) 0.48 (0.19–1.19) 0.106
Spinal surgery 15 (24.6%) 12 (17.9%) 0.67 (0.29–1.57) 0.355
Fever 19 (31.1%) 28 (41.8%) 1.59 (0.77–3.29) 0.212
Spine pain 61 (100%) 65 (97.0%) — 0.497
Motor dysfunction 8 (13.1%) 5 (7.5%) 0.53 (0.17–1.73) 0.290
Sepsis 14 (23.0%) 23 (34.3%) 1.76 (0.80–3.83) 0.156
White blood cell count (× 106/μL) 9.10 (6.40–12.75) 10.30 (7.30–14.55) 1.06 (0.99–1.14) 0.082 0.99 (0.92–1.07) 0.771
C-reactive protein (mg/dL) 4.7 (2.0–10.4) 9.5 (4.5–18.5) 1.08 (1.03–1.14) 0.002 1.07 (1.01–1.15) 0.032
Presence of abscesses
Epidural 45 (73.8%) 42 (62.7%) 0.60 (0.28–1.27) 0.179
Paravertebral 55 (90.2%) 53 (79.1%) 0.41 (0.14–1.16) 0.085 0.95 (0.32–2.78) 0.921
Psoas 17 (27.8%) 24 (35.8%) 1.45 (0.68–3.06) 0.336
Blood culture positivity 13 (27.1%) 35 (63.6%) 4.71 (2.03–10.9) <0.001 2.57 (1.01–6.59) 0.049
Biopsy site
Vertebral body 44 (65.7%) 29 (42.0%) 1.00 1.00
Soft tissue 23 (34.3%) 40 (58.0%) 2.64 (1.33–5.24) 0.006 2.28 (1.08–4.78) 0.030
934 Clinical Microbiology and Infection, Volume 21 Number 10, October 2015 CMIanalysis revealed that obtaining specimens from soft tissues was
an independent factor associated with culture positivity. We
suggest that this reﬂects the higher burden of bacteria in ab-
scesses, the burden of bacteria in vertebral bodies being
considerably lower. We conclude that soft tissues are the best
sites for microbiological diagnosis in patients with PVO, and
recommend using these sites when needle biopsy is performed.
It is well known that the level of CRP is higher in patients
with culture positive PVO [1,2,14]. In contrast male gender has
not previously been reported to be an independent factor
associated with tissue-culture positivity in patients with PVO.
The culture positive rates for males and females were 60.0%
(48/80) and 39.6% (19/48), respectively. We are unable to
explain why male gender is an independent factor associated
with tissue-culture positivity.
Histological studies of specimens can be helpful in diagnosing
vertebral osteomyelitis, especially when it is caused by
M. tuberculosis, or Brucella, because the presence of granulomas
points to the diagnosis [11,18,19]. Pathological ﬁndings of bone
biopsy specimens are also important in differentiating meta-
static cancer [20]. Specimens for histology can be obtained
from vertebral bodies but are not easily obtained from soft
tissues. This point should be considered when choosing a bi-
opsy site, especially when there is suspicion of spondylitis
caused by M. tuberculosis or Brucella.
Our study had several limitations. Although it involved the
largest number of tissues of different anatomical categories
from patients with PVO so far, the number of cases in which
tissues were obtained from two anatomical categories was
relatively small. Obtaining tissues from different anatomicalClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectcategories in the same patients would make it easier to
determine which sites are best for microbiological diagnosis.
Second, it is a retrospective study and there may be unrecog-
nized confounding factors associated with tissue-culture
positivity.
In conclusion, male gender, higher CRP, positive blood cul-
ture and soft tissues as biopsy sites are independent factors
associated with culture positivity of tissues obtained by needle
biopsy in patients with PVO. Soft tissues appear to be the best
sites for obtaining tissue for microbiological diagnosis by needle
biopsy in these patients.Transparency DeclarationThe authors have no conﬂicts of interest to report.AcknowledgementsThis work was supported by a grant from the research fund of
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